Does INGENOL MEBUTATE Cause Application site vesicles? 843 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 843 reports of Application site vesicles have been filed in association with INGENOL MEBUTATE. This represents 27.9% of all adverse event reports for INGENOL MEBUTATE.
843
Reports of Application site vesicles with INGENOL MEBUTATE
27.9%
of all INGENOL MEBUTATE reports
0
Deaths
4
Hospitalizations
How Dangerous Is Application site vesicles From INGENOL MEBUTATE?
Of the 843 reports, 4 (0.5%) required hospitalization.
Is Application site vesicles Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INGENOL MEBUTATE. However, 843 reports have been filed with the FAERS database.
What Other Side Effects Does INGENOL MEBUTATE Cause?
Application site erythema (1,373)
Application site pain (1,012)
Application site exfoliation (586)
Drug administered at inappropriate site (500)
Application site swelling (489)
Application site scab (451)
Application site dryness (365)
Incorrect drug administration duration (339)
Application site pruritus (291)
Inappropriate schedule of drug administration (250)
What Other Drugs Cause Application site vesicles?
BUPRENORPHINE (700)
SUMATRIPTAN (262)
NICOTINE (241)
MINOXIDIL (188)
ESTRADIOL (179)
FENTANYL (170)
PICATO (139)
DICLOFENAC (115)
CHLORHEXIDINE\ISOPROPYL ALCOHOL (80)
MECHLORETHAMINE (73)
Which INGENOL MEBUTATE Alternatives Have Lower Application site vesicles Risk?
INGENOL MEBUTATE vs INLYTA
INGENOL MEBUTATE vs INOTERSEN
INGENOL MEBUTATE vs INOTUZUMAB OZOGAMICIN
INGENOL MEBUTATE vs INSULIN
INGENOL MEBUTATE vs INSULIN ASPART